-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FQEhLlEyPLjnPqitepTIPdWuIUYq3jq5fR4XUcXcIQX7hs9XnM+5YJmhvYyCSSjP nM5tIrqba9I8jsg53qgllg== 0001181431-10-041124.txt : 20100810 0001181431-10-041124.hdr.sgml : 20100810 20100810135056 ACCESSION NUMBER: 0001181431-10-041124 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100806 FILED AS OF DATE: 20100810 DATE AS OF CHANGE: 20100810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kjellson Nina S CENTRAL INDEX KEY: 0001381980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34828 FILM NUMBER: 101004457 MAIL ADDRESS: STREET 1: C/O INTERWEST PARTNERS STREET 2: 2710 SAND HILL ROAD, SECOND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trius Therapeutics Inc CENTRAL INDEX KEY: 0001356857 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201320630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-452-0370 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd283399.xml FORM 4 X0303 4 2010-08-06 0 0001356857 Trius Therapeutics Inc TSRX 0001381980 Kjellson Nina S C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121 1 0 1 0 Common Stock 2010-08-06 4 C 0 1576814 A 1576814 I See Footnote Common Stock 2010-08-06 4 C 0 744496 4.38 A 2321310 I See Footnote Common Stock 2010-08-06 4 P 0 1227333 5.00 A 3548643 I See Footnote Series A-2 Convertible Preferred Stock 2010-08-06 4 C 0 9090910 D Common Stock 9090910 0 I See Footnote Series B Convertible Preferred Stock 2010-08-06 4 C 0 4469697 D Common Stock 4469697 0 I See Footnote Upon the closing of the Issuer's initial public offering, each 8.6 shares of the Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into one share of Common Stock, and had no expiration date. The shares are held by InterWest Partners IX, L.P. The Reporting Person shares voting and investment authority over the shares held by InterWest Partners IX, L.P. The Reporting Person may be deemed to beneficially own the shares and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. The Common Stock was acquired upon conversion of a Secured Convertible Promissory Note exempt from the definition of a derivative security and whose conversion ratio did not become fixed until automatic conversion at the time of the closing of the Issuer's initial public offering. The shares were purchased in the Issuer's initial public offering and are held by InterWest Partners IX, L.P. The Reporting Person shares voting and investment authority over the shares held by InterWest Partners IX, L.P. The Reporting Person may be deemed to beneficially own the shares and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. /s/ Karen A. Wilson, Attorney-in-fact 2010-08-09 -----END PRIVACY-ENHANCED MESSAGE-----